Impact of variation in functions and delivery on the effectiveness of behavioural and mood management interventions for smoking cessation in people with depression: Protocol for a systematic review and meta-analysis

Gemma Taylor, Paul Aveyard, Regina Van Der Meer, Daniel Toze, Bobby Stuijfzand, David Kessler, Marcus Munafò

Research output: Contribution to journalReview article

22 Downloads (Pure)

Abstract

Introduction Tobacco is the world's leading preventable cause of disease and death. People with depression are twice as likely to smoke and are less responsive to standard tobacco treatments as compared with the general population. A Cochrane systematic review of randomised controlled trials of smoking cessation treatment for smokers with current or historical depression found that adding mood management to usual smoking treatment improved quit rates. However, the review did not examine if variation in intervention delivery or intervention functions impacted on treatment effectiveness. With the aim of providing information to develop tailored approaches to treating smoking for people with current depression, we will add-on to the Cochrane review in three ways: (1) use the Template for Intervention Description and Replication checklist to determine if variations in mood management delivery have impact on intervention effectiveness, (2) use the Taxonomy of Behaviour Change techniques for smoking cessation to examine which behaviour change functions are most effective for smoking cessation in people with current depression and (3) examine the difference in change in depression scores between intervention and control arms. Methods and analysis We will include randomised controlled trials of smokers with current depression as identified by a previous Cochrane review and the in-progress update of this Cochrane review. We will use meta-regression to examine (1) if variations in delivery of mood management impact on smoking cessation intervention effectiveness, (2) determine which behaviour change functions are most effective for smoking cessation and (3) use meta-analysis of the difference in change in depression scores between treatment arms from baseline to follow-up to determine if offering smoking cessation treatment causes psychological harm. Ethics and dissemination Ethical approval is not required for this study. We will disseminate the findings of this work at national and international conferences, and to relevant patient panels. PROSPERO registration number CRD42017070741.

Original languageEnglish
Article number018617
JournalBMJ Open
Volume7
Issue number11
DOIs
Publication statusPublished - 16 Nov 2017

Keywords

  • Depression
  • Intervention
  • Protocol
  • Smoking cessation
  • Systematic review
  • Tobacco

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Impact of variation in functions and delivery on the effectiveness of behavioural and mood management interventions for smoking cessation in people with depression : Protocol for a systematic review and meta-analysis. / Taylor, Gemma; Aveyard, Paul; Van Der Meer, Regina; Toze, Daniel; Stuijfzand, Bobby; Kessler, David; Munafò, Marcus.

In: BMJ Open, Vol. 7, No. 11, 018617, 16.11.2017.

Research output: Contribution to journalReview article

@article{588d329285db42f4b907b84ec8be6030,
title = "Impact of variation in functions and delivery on the effectiveness of behavioural and mood management interventions for smoking cessation in people with depression: Protocol for a systematic review and meta-analysis",
abstract = "Introduction Tobacco is the world's leading preventable cause of disease and death. People with depression are twice as likely to smoke and are less responsive to standard tobacco treatments as compared with the general population. A Cochrane systematic review of randomised controlled trials of smoking cessation treatment for smokers with current or historical depression found that adding mood management to usual smoking treatment improved quit rates. However, the review did not examine if variation in intervention delivery or intervention functions impacted on treatment effectiveness. With the aim of providing information to develop tailored approaches to treating smoking for people with current depression, we will add-on to the Cochrane review in three ways: (1) use the Template for Intervention Description and Replication checklist to determine if variations in mood management delivery have impact on intervention effectiveness, (2) use the Taxonomy of Behaviour Change techniques for smoking cessation to examine which behaviour change functions are most effective for smoking cessation in people with current depression and (3) examine the difference in change in depression scores between intervention and control arms. Methods and analysis We will include randomised controlled trials of smokers with current depression as identified by a previous Cochrane review and the in-progress update of this Cochrane review. We will use meta-regression to examine (1) if variations in delivery of mood management impact on smoking cessation intervention effectiveness, (2) determine which behaviour change functions are most effective for smoking cessation and (3) use meta-analysis of the difference in change in depression scores between treatment arms from baseline to follow-up to determine if offering smoking cessation treatment causes psychological harm. Ethics and dissemination Ethical approval is not required for this study. We will disseminate the findings of this work at national and international conferences, and to relevant patient panels. PROSPERO registration number CRD42017070741.",
keywords = "Depression, Intervention, Protocol, Smoking cessation, Systematic review, Tobacco",
author = "Gemma Taylor and Paul Aveyard and {Van Der Meer}, Regina and Daniel Toze and Bobby Stuijfzand and David Kessler and Marcus Munaf{\`o}",
year = "2017",
month = "11",
day = "16",
doi = "10.1136/bmjopen-2017-018617",
language = "English",
volume = "7",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "11",

}

TY - JOUR

T1 - Impact of variation in functions and delivery on the effectiveness of behavioural and mood management interventions for smoking cessation in people with depression

T2 - Protocol for a systematic review and meta-analysis

AU - Taylor, Gemma

AU - Aveyard, Paul

AU - Van Der Meer, Regina

AU - Toze, Daniel

AU - Stuijfzand, Bobby

AU - Kessler, David

AU - Munafò, Marcus

PY - 2017/11/16

Y1 - 2017/11/16

N2 - Introduction Tobacco is the world's leading preventable cause of disease and death. People with depression are twice as likely to smoke and are less responsive to standard tobacco treatments as compared with the general population. A Cochrane systematic review of randomised controlled trials of smoking cessation treatment for smokers with current or historical depression found that adding mood management to usual smoking treatment improved quit rates. However, the review did not examine if variation in intervention delivery or intervention functions impacted on treatment effectiveness. With the aim of providing information to develop tailored approaches to treating smoking for people with current depression, we will add-on to the Cochrane review in three ways: (1) use the Template for Intervention Description and Replication checklist to determine if variations in mood management delivery have impact on intervention effectiveness, (2) use the Taxonomy of Behaviour Change techniques for smoking cessation to examine which behaviour change functions are most effective for smoking cessation in people with current depression and (3) examine the difference in change in depression scores between intervention and control arms. Methods and analysis We will include randomised controlled trials of smokers with current depression as identified by a previous Cochrane review and the in-progress update of this Cochrane review. We will use meta-regression to examine (1) if variations in delivery of mood management impact on smoking cessation intervention effectiveness, (2) determine which behaviour change functions are most effective for smoking cessation and (3) use meta-analysis of the difference in change in depression scores between treatment arms from baseline to follow-up to determine if offering smoking cessation treatment causes psychological harm. Ethics and dissemination Ethical approval is not required for this study. We will disseminate the findings of this work at national and international conferences, and to relevant patient panels. PROSPERO registration number CRD42017070741.

AB - Introduction Tobacco is the world's leading preventable cause of disease and death. People with depression are twice as likely to smoke and are less responsive to standard tobacco treatments as compared with the general population. A Cochrane systematic review of randomised controlled trials of smoking cessation treatment for smokers with current or historical depression found that adding mood management to usual smoking treatment improved quit rates. However, the review did not examine if variation in intervention delivery or intervention functions impacted on treatment effectiveness. With the aim of providing information to develop tailored approaches to treating smoking for people with current depression, we will add-on to the Cochrane review in three ways: (1) use the Template for Intervention Description and Replication checklist to determine if variations in mood management delivery have impact on intervention effectiveness, (2) use the Taxonomy of Behaviour Change techniques for smoking cessation to examine which behaviour change functions are most effective for smoking cessation in people with current depression and (3) examine the difference in change in depression scores between intervention and control arms. Methods and analysis We will include randomised controlled trials of smokers with current depression as identified by a previous Cochrane review and the in-progress update of this Cochrane review. We will use meta-regression to examine (1) if variations in delivery of mood management impact on smoking cessation intervention effectiveness, (2) determine which behaviour change functions are most effective for smoking cessation and (3) use meta-analysis of the difference in change in depression scores between treatment arms from baseline to follow-up to determine if offering smoking cessation treatment causes psychological harm. Ethics and dissemination Ethical approval is not required for this study. We will disseminate the findings of this work at national and international conferences, and to relevant patient panels. PROSPERO registration number CRD42017070741.

KW - Depression

KW - Intervention

KW - Protocol

KW - Smoking cessation

KW - Systematic review

KW - Tobacco

UR - http://www.scopus.com/inward/record.url?scp=85049407511&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2017-018617

DO - 10.1136/bmjopen-2017-018617

M3 - Review article

C2 - 29150479

AN - SCOPUS:85049407511

VL - 7

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 11

M1 - 018617

ER -